Clinical Trial: A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07014488) titled 'A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects' on June 03.

Brief Summary: The study was designed to evaluate the pharmacokinetic effects of Rifampicin on HRS-5041 after oral administration of HRS-5041 tablets in healthy subjects.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Prostate Cancer

Intervention: DRUG: HRS-5041 Tablets

HRS-5041 tablets.

DRUG: Rifampicin Capsule

Rifampicin capsule.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Dai...